Cover Image
市場調查報告書

出血:全球臨床實驗趨勢

Hemorrhage Global Clinical Trials Review, H1, 2015

出版商 GlobalData 商品編碼 217240
出版日期 內容資訊 英文 78 Pages
訂單完成後即時交付
價格
Back to Top
出血:全球臨床實驗趨勢 Hemorrhage Global Clinical Trials Review, H1, 2015
出版日期: 2015年06月30日 內容資訊: 英文 78 Pages
簡介

本報告提供出血臨床實驗相關之最新趨勢分析,提供您各地區臨床實驗數量,臨床實驗各階段進展,實驗對象採用狀況,並彙整有潛力的贊助商,各企業和研究機關的研究進展,有潛力的藥劑比較等資訊。

簡介

  • 出血
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要5國的臨床實驗數量
    • 歐洲主要5國的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東·非洲主要5國的臨床實驗數量
    • 中南美主要5國的臨床實驗數量

G7各國臨床實驗數量:血液疾病治療藥臨床實驗上出血所佔的比例

G7各國的各階段臨床實驗數量

G7各國臨床實驗數量:各進展狀況

E7各國臨床實驗數量:血液疾病治療藥臨床實驗上出血所佔的比例

E7各國的各階段臨床實驗數量

E7各國臨床實驗數量:各進展狀況

各階段臨床實驗數量

  • 進行中的臨床實驗:各階段

各進展狀況臨床實驗數量

臨床實驗的目標達成情形

未完成的臨床實驗數量

一定期間所採用的實驗對象

贊助商類別的臨床實驗數量

有潛力的贊助商

出血臨床實驗主要的參與企業

有潛力的藥劑

臨床實驗簡介

  • 主要企業臨床實驗概要
    • Gynuity Health Projects
    • Johnson & Johnson
    • Pfizer Inc.
    • CSL Limited
    • 武田藥品工業
    • Merck & Co., Inc.
    • Bayer AG
    • RTI International
    • Ferring International Center S.A.
    • C. H. Boehringer Sohn AG & Co. KG
  • 有代表性的研究機關·醫院臨床實驗概要
    • Tehran University of Medical Sciences
    • Ain Shams University
    • Cairo University
    • Rigshospitalet
    • The Lunenfeld-Tanenbaum Research Institute
    • Chinese University of Hong Kong
    • Kashan University of Medical Sciences and Health Services
    • Qazvin University Of Medical Sciences
    • Aga Khan University
    • Asan Medical Center

5個有代表性的臨床實驗簡介

附錄

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC2749CTIDB

GlobalData's clinical trial report, "Hemorrhage Global Clinical Trials Review, H1, 2015" provides an overview of Hemorrhage clinical trials scenario. This report provides top line data relating to the clinical trials on Hemorrhage. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Hemorrhage
    • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Five Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
      • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Hemorrhage to Hematological Disorders Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Unaccomplished Trials of Hemorrhage
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
    • Top Companies Participating in Hemorrhage Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
      • Gynuity Health Projects
      • Clinical Trial Overview of Gynuity Health Projects
      • Johnson & Johnson
      • Clinical Trial Overview of Johnson & Johnson
      • Pfizer Inc.
      • Clinical Trial Overview of Pfizer Inc.
      • CSL Limited
      • Clinical Trial Overview of CSL Limited
      • Takeda Pharmaceutical Company Limited
      • Clinical Trial Overview of Takeda Pharmaceutical Company Limited
      • Merck & Co., Inc.
      • Clinical Trial Overview of Merck & Co., Inc.
      • Bayer AG
      • Clinical Trial Overview of Bayer AG
      • RTI International
      • Clinical Trial Overview of RTI International
      • Ferring International Center S.A.
      • Clinical Trial Overview of Ferring International Center S.A.
      • C. H. Boehringer Sohn AG & Co. KG
      • Clinical Trial Overview of C. H. Boehringer Sohn AG & Co. KG
    • Clinical Trial Overview of Top Institutes / Government
      • Tehran University of Medical Sciences
      • Clinical Trial Overview of Tehran University of Medical Sciences
      • Ain Shams University
      • Clinical Trial Overview of Ain Shams University
      • Cairo University
      • Clinical Trial Overview of Cairo University
      • Rigshospitalet
      • Clinical Trial Overview of Rigshospitalet
      • The Lunenfeld-Tanenbaum Research Institute
      • Clinical Trial Overview of The Lunenfeld-Tanenbaum Research Institute
      • Chinese University of Hong Kong
      • Clinical Trial Overview of Chinese University of Hong Kong
      • Kashan University of Medical Sciences and Health Services
      • Clinical Trial Overview of Kashan University of Medical Sciences and Health Services
      • Qazvin University Of Medical Sciences
      • Clinical Trial Overview of Qazvin University Of Medical Sciences
      • Aga Khan University
      • Clinical Trial Overview of Aga Khan University
      • Asan Medical Center
      • Clinical Trial Overview of Asan Medical Center
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Hemorrhage Therapeutics, Global, Clinical Trials by Region, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, North America, Top Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015*
  • Proportion of Hemorrhage to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hemorrhage to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials by Phase, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hemorrhage Therapeutics, Global, Suspended Clinical Trials, 2015*
  • Hemorrhage Therapeutics, Global, Withdrawn Clinical Trials, 2015*
  • Hemorrhage Therapeutics, Global, Terminated Clinical Trials, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Gynuity Health Projects, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson & Johnson, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Pharmaceutical Company Limited, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by RTI International, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Ferring International Center S.A., 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by C. H. Boehringer Sohn AG & Co. KG, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Tehran University of Medical Sciences, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Ain Shams University, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Cairo University, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by The Lunenfeld-Tanenbaum Research Institute, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Kashan University of Medical Sciences and Health Services, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Qazvin University Of Medical Sciences, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Aga Khan University, 2015*
  • Hemorrhage Therapeutics Clinical Trials Market, Global, Clinical Trials by Asan Medical Center, 2015*

List of Figures

  • Hemorrhage Therapeutics, Global, Clinical Trials by Region (%), 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015*
  • Hemorrhage Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015*
  • Hemorrhage Therapeutics Clinical Trials, North America, Top Countries (%), 2015*
  • Hemorrhage Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2015*
  • Hemorrhage Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015*
  • Proportion of Hemorrhage to Hematological Disorders Clinical Trials, G7 Countries (%), 2015*
  • Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Phase, 2015*
  • Hemorrhage Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015*
  • Proportion of Hemorrhage to Hematological Disorders Clinical Trials, E7 Countries (%), 2015*
  • Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Phase, 2015*
  • Hemorrhage Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials by Phase (%), 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials In Progress by Phase, 2015*
  • Hemorrhage Therapeutics, Global, Clinical Trials by Trial Status, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, by End Point Status, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014
  • Hemorrhage Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Key Sponsors, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015*
  • Hemorrhage Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015*
  • GlobalData Methodology
Back to Top